Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 105
Filter
1.
J Laryngol Otol ; 135(4): 297-303, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33785085

ABSTRACT

BACKGROUND: The prognosis of patients with advanced squamous cell carcinoma of the external auditory canal and middle ear has been improved by advances in skull base surgery and multidrug chemoradiotherapy during the last two decades. METHODS: Ninety-five patients with squamous cell carcinoma of the external auditory canal and middle ear who were treated between 1998 and 2017 were enrolled. The number of patients with tumour stages T1, T2, T3 and T4 was 15, 22, 24 and 34, respectively. Oncological outcomes and prognostic factors were retrospectively investigated. RESULTS: Among patients with T4 disease, invasion of the brain (p = 0.024), carotid artery (p = 0.049) and/or jugular vein (p = 0.040) were significant predictors of poor prognosis. The five-year overall survival rate of patients with at least one of these factors (T4b) was significantly lower than that of patients without these factors (T4a) (25.5 vs 65.5 per cent, p = 0.049). CONCLUSION: It is proposed that stage T4 be subclassified into T4a and T4b according to the prognostic factors.


Subject(s)
Carcinoma, Squamous Cell/classification , Ear Neoplasms/classification , Neoplasm Staging/classification , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/pathology , Ear Canal/pathology , Ear Neoplasms/pathology , Ear, Middle/pathology , Female , Humans , Male , Middle Aged , Prognosis , Retrospective Studies
2.
J Chemother ; 23(6): 367-70, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22233823

ABSTRACT

Small cell lung cancer with interstitial lung disease (ILD-SCLC) is difficult to treat because of the risk of fatal pneumonitis. Our study aims to evaluate the validity of topotecan (TOP) as chemotherapy for patients with relapsed ILD-SCLC. Overall survival was compared between TOP and other drugs as second-line treatments for ILD-SCLC patients. Forty-seven patients began chemotherapy and second-line treatment was administered in 48.5% of relapsed cases. The response rate of TOP for second-line therapy was 16.7%. Hematologic toxicities were grade 4 anemia, grade 3 neutropenia and grade 3 thrombocytopenia. Mild pulmonary toxicity was observed in 1 case. Patients receiving TOP as second-line treatment showed no significant difference in survival when compared to patients who underwent other regimens (median survival time 179 vs. 76 days; p =0.76). TOP is a well tolerated drug and is a viable candidate for second-line treatment of ILD-SCLC patients.


Subject(s)
Antineoplastic Agents/therapeutic use , Lung Diseases, Interstitial/complications , Lung Neoplasms/complications , Lung Neoplasms/drug therapy , Small Cell Lung Carcinoma/complications , Small Cell Lung Carcinoma/drug therapy , Topotecan/therapeutic use , Aged , Aged, 80 and over , Antineoplastic Agents/adverse effects , Female , Humans , Male , Middle Aged , Retrospective Studies , Topotecan/adverse effects
3.
Histol Histopathol ; 25(7): 933-44, 2010 07.
Article in English | MEDLINE | ID: mdl-20503181

ABSTRACT

Retinitis pigmentosa (RP) is a group of inherited neurodegenerative diseases in humans characterized by loss of photoreceptor cells leading to visual disturbance and eventually to blindness. A single systemic administration of N-methyl-N-nitrosourea (MNU) causes retinal degeneration in various animal species. The retinal degeneration is highly reproducible, and the photoreceptor cell loss occurs within seven days after MNU administration via apoptosis resembling human RP. Here, we describe the disease progression, disease mechanisms, and therapeutic trials of MNU-induced retinal degeneration.


Subject(s)
Methylnitrosourea , Nitrosourea Compounds/adverse effects , Retinitis Pigmentosa/chemically induced , Animals , Apoptosis/drug effects , Methylnitrosourea/adverse effects , Methylnitrosourea/pharmacology , Mice , Models, Animal , Photoreceptor Cells , Rats , Retinal Degeneration/chemically induced
4.
Histol Histopathol ; 24(2): 223-34, 2009 02.
Article in English | MEDLINE | ID: mdl-19085838

ABSTRACT

International variation in breast and colon cancer incidence is positively related to total fat intake. However, total fat consists of different fatty acid families, e.g., saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and n-3 and n-6 polyunsaturated fatty acids (PUFAs). Epidemiological evidence and experimental studies suggest that these fatty acid families have different effects on breast and colon carcinogenesis. Therefore the action of each fatty acid on carcinogenesis should be evaluated separately. Although it is difficult to establish firm conclusions on the effect of each fatty acid in human epidemiological studies, experimental studies on animals and cultured cells suggest that n-6 PUFAs (linoleic acid and arachidonic acid) may have a tumor promoting effect, while n-3 PUFAs (eicosapentaenoic acid, docosahexaenoic acid and alpha-linolenic acid) and conjugated fatty acids (CFAs; a mixture of positional and geometric isomers of PUFAs with conjugated double bonds) exert an inhibitory effect on tumor growth. SFAs such as palmitic acid and stearic acid show little or no tumor promoting effect, and the action of oleic acid, a MUFA, is inconclusive. In addition to regulation of abnormal cell growth seen in cancers, fatty acids also control cell loss seen in degenerative eye diseases, such as degeneration of lens material in cataract and degeneration of photoreceptor cells in retinitis pigmentosa. Experiments suggest that n-6 PUFAs cause deleterious effects, while n-3 PUFAs result in beneficial effects on the lens and retina. In particular, docosahexaenoic acid is known to be effective in rescuing photoreceptor cells from damage. Thus, understanding the function of each fatty acid is likely to be important for making progress in treating these and other diseases.


Subject(s)
Breast Neoplasms/metabolism , Colonic Neoplasms/metabolism , Fatty Acids/metabolism , Retinitis Pigmentosa/metabolism , Vision Disorders/metabolism , Animals , Breast Neoplasms/epidemiology , Colonic Neoplasms/epidemiology , Fatty Acids, Unsaturated/metabolism , Humans , Lens, Crystalline/metabolism , Models, Chemical , Rats , Retinitis Pigmentosa/epidemiology , Risk , Vision Disorders/epidemiology , alpha-Linolenic Acid/pharmacology
5.
Oncogene ; 26(36): 5258-66, 2007 Aug 09.
Article in English | MEDLINE | ID: mdl-17325661

ABSTRACT

In human cells, telomerase activity is tightly regulated by the expression of its catalytic subunit, namely, the human telomerase reverse transcriptase (hTERT). However, the molecular mechanisms involved in the regulation of hTERT expression have not been completely clarified. We have previously reported that transforming growth factor beta (TGF-beta) represses the expression of the hTERT gene. In the present study, we demonstrated that TGF-beta-activated kinase 1 (TAK1), originally identified as a mitogen-activated kinase kinase kinase, represses the hTERT core promoter activity in an E-box-independent manner, and it also represses the transcription of the hTERT gene in human lung adenocarcinoma cell line, A549 cells. This TAK1-induced repression was found to be caused by the recruitment of histone deacetylase to Sp1 at the hTERT promoter and a consequent reduction in the amount of acetylated histone H4 at the hTERT promoter. Finally, we demonstrated that TAK1 induces cellular senescence programs in normal human diploid cells. Thus, we assume that TAK1 triggers the repression mechanisms of the hTERT gene as a result of evoking cellular senescence programs. Considered together, TAK1 is thought to play a causative role in the determination of a finite replicative lifespan of normal and cancer cells.


Subject(s)
MAP Kinase Kinase Kinases/physiology , RNA Splicing , Telomerase/genetics , Transcription, Genetic/physiology , Base Sequence , Blotting, Western , Cell Line, Tumor , DNA Primers , DNA, Complementary , Electrophoretic Mobility Shift Assay , Histone Deacetylases/metabolism , Humans , Immunoprecipitation , MAP Kinase Kinase Kinases/metabolism , Promoter Regions, Genetic , RNA, Messenger/genetics , RNA, Small Interfering , Reverse Transcriptase Polymerase Chain Reaction , Sp1 Transcription Factor/metabolism
6.
World J Gastroenterol ; 12(36): 5793-7, 2006 Sep 28.
Article in English | MEDLINE | ID: mdl-17007044

ABSTRACT

AIM: To examine human beta-defensin-3 (hBD-3) expression in inflamed gastric mucosal tissues or MKN45 gastric cancer cells with or without H. pylori infection for better understanding the innate immune response to H. pylori. METHODS: We used reverse transcription-polymerase chain reactions and immunohistochemistry to examine hBD-3 expression in inflamed gastric mucosal tissues or MKN45 gastric cancer cells with or without H. pylori. Effects of hBD-3 against H. pylori were also evaluated. RESULTS: The mean mRNA expression of hBD-3 in H. pylori-positive specimens was significantly higher than that in H pylori-negative specimens (P = 0.0002, Mann-Whitney). In addition, unlike uninfected samples, 8 of 15 (53.33%) infected mucosal samples expressed hBD-3 protein. H. pylori dose-dependently induced mRNA expression of hBD-3 in MKN45 cells, an effect inhibited by adding anti-toll-like receptor (TLR)-4 antibody. HBD-3 protein completely inhibited H. pylori growth. CONCLUSION: Our results suggest that like hBD-2, hBD-3 may be involved in the pathophysiology of H. pylori-induced gastritis.


Subject(s)
Gastric Mucosa/metabolism , Gastritis/metabolism , Helicobacter Infections/metabolism , beta-Defensins/metabolism , Antibodies, Anti-Idiotypic/immunology , Antibodies, Anti-Idiotypic/pharmacology , Cell Line, Tumor , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Gastritis/genetics , Gastritis/microbiology , Gastritis/physiopathology , Gene Expression Regulation , Gene Expression Regulation, Neoplastic , Helicobacter Infections/genetics , Helicobacter Infections/physiopathology , Helicobacter pylori/drug effects , Helicobacter pylori/pathogenicity , Humans , RNA, Messenger/genetics , RNA, Messenger/metabolism , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism , Toll-Like Receptor 4/immunology , beta-Defensins/genetics , beta-Defensins/pharmacology
7.
Toxicol Sci ; 80(1): 109-14, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15014208

ABSTRACT

Until recently it has been generally considered that genotoxic carcinogens have no threshold in exerting their potential for cancer induction. However, the nonthreshold theory can be challenged with regard to assessment of cancer risk to humans. In the present study we show that a food derived, genotoxic hepatocarcinogen, 2-amino-1-methyl-6-phenolimidazo[4,5-b]pyridine (PhIP), does not induce aberrant crypt foci (ACF) as preneoplastic lesions at low dose (below 50 ppm) or 8-hydroxy-2'-deoxyguanosine (below 400 ppm) in the rat colon. Moreover PhIP-DNA adducts were not formed at the lowest dose (below 0.01 ppm). Thus, the dose required to initiate ACF is approximately 5000 times higher than that needed for adduct formation. The results imply a no-observed effect level (existence of a threshold) for colon carcinogenesis by a genotoxic carcinogen.


Subject(s)
Carcinogens/toxicity , Colon/drug effects , Deoxyguanosine/analogs & derivatives , Imidazoles/toxicity , Mutagens/toxicity , 8-Hydroxy-2'-Deoxyguanosine , Animals , Carcinogens/administration & dosage , Colon/metabolism , Colon/pathology , Colonic Neoplasms/chemically induced , Colonic Neoplasms/pathology , DNA Adducts/biosynthesis , DNA Adducts/metabolism , Deoxyguanosine/metabolism , Dose-Response Relationship, Drug , Imidazoles/administration & dosage , Imidazoles/metabolism , Male , Mutagenicity Tests , Mutagens/administration & dosage , No-Observed-Adverse-Effect Level , Precancerous Conditions/chemically induced , Precancerous Conditions/pathology , Rats , Rats, Inbred F344
8.
J Med Microbiol ; 52(Pt 1): 41-45, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12488564

ABSTRACT

The objective of this study was to understand more of the innate immune response to Helicobacter pylori by determining the expression of human beta-defensin-2 (hBD-2) in various gastric mucosal tissues and MKN45 gastric cancer cells with or without H. pylori. Semi-quantitative TaqMan RT-PCR and immunohistochemistry were carried out. The antimicrobial effects of a transfected hBD-2 gene against H. pylori were also evaluated. The results showed that hBD-2 was expressed in inflamed gastric mucosal tissues with H. pylori infection, but not in the absence of H. pylori infection. Expression was also detected in gastric cancers in patients with H. pylori infection. Expression was induced in the MKN45 gastric cancer cell line by H. pylori in a manner dependent on the abundance of bacteria. hBD-2-transfected 3T3J2-1 cells secreted hBD-2 protein into the culture medium and this protein inhibited growth of H. pylori completely. The results suggest that hBD-2 may be involved in the pathophysiology of H. pylori-induced gastritis.


Subject(s)
Gastric Mucosa/microbiology , Gene Expression Regulation , Helicobacter Infections/genetics , Helicobacter Infections/immunology , Helicobacter pylori/immunology , beta-Defensins/genetics , beta-Defensins/immunology , Adult , Colony Count, Microbial , Enterococcus faecalis/physiology , Escherichia coli/physiology , Gastric Mucosa/chemistry , Gastric Mucosa/immunology , Gastritis/immunology , Gastritis/microbiology , Helicobacter pylori/isolation & purification , Helicobacter pylori/physiology , Humans , Immunity, Innate , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Salmonella typhimurium/physiology , Staphylococcus aureus/physiology , Stomach Neoplasms/immunology , Stomach Neoplasms/microbiology , Transfection , Tumor Cells, Cultured , beta-Defensins/analysis
9.
Lett Appl Microbiol ; 35(1): 62-7, 2002.
Article in English | MEDLINE | ID: mdl-12081552

ABSTRACT

AIMS: The aim of this study was to analyse genotypes for clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA), including hetero-vancomycin-resistant Staph. aureus (VRSA), at a Japanese university hospital. METHODS AND RESULTS: Seventy-eight clinical isolates of MRSA were analysed by arbitrarily primed-polymerase chain reaction (AP-PCR) using ERIC2 primer and by pulse-field gel electrophoresis (PFGE) following SmaI digestion. Analyses of the nine genotypes and 28 subtypes defined by PFGE, and of the three genotypes and 22 subtypes defined by AP-PCR, both facilitated epidemiological tracing. Used in combination, AP-PCR and PFGE provided more precise classification than the use of a single genotyping method. The six hetero-VRSA isolates were classified into four genotypes defined by the combination of both methods, but these genotypes contained non-VRSA isolates. CONCLUSIONS: The results suggest that both PFGE and AP-PCR are useful in discriminating MRSA, but not hetero-VRSA, isolates for epidemiological analysis. SIGNIFICANCE AND IMPACT OF THE STUDY: Combining the results of PFGE with the results of AP-PCR can provide more detail differentiation of MRSA and hetero-MRSA isolates than either method alone.


Subject(s)
Electrophoresis, Gel, Pulsed-Field/methods , Methicillin Resistance , Polymerase Chain Reaction/methods , Staphylococcus aureus/classification , DNA, Bacterial/analysis , Genome, Bacterial , Genotype , Humans , Japan/epidemiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Vancomycin Resistance
10.
Epidemiol Infect ; 128(2): 337-42, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12002553

ABSTRACT

Thirty Japanese clinical isolates of Mycobacterium tuberculosis were analysed by pyrazinamide susceptibility testing and pyrazinamidase assay, as well as polymerase chain reaction for single-strand conformational polymorphism and direct sequencing of the gene encoding pyrazinamidase (pncA). All sensitive isolates showed pyrazinamidase activity and a wild-type pncA gene, but three resistant isolates had pncA gene mutations and lacked pyrazinamidase activity. The latter isolates showed a minimum inhibitory concentration of at least 100 mg/l by the 7H10 agar proportion method and 400 mg/l by the 7H9 liquid medium method. Isolate 28 showed T-to-C change at position 11, leading to Leu4 --> Ser substitution; isolate 29 had an 8-bp deletion from position 382; and isolate 30 had A-to-C change at position 29, leading to Gln10 --> Pro substitution. The deletion has not been described previously. This is the first demonstration of pncA gene mutations in PZA-resistant M. tuberculosis strains isolated from Japanese patients.


Subject(s)
Amidohydrolases/genetics , Antitubercular Agents/pharmacology , DNA, Bacterial/genetics , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/genetics , Pyrazinamide/pharmacology , DNA Mutational Analysis , DNA Primers , Dose-Response Relationship, Drug , Drug Resistance/genetics , Humans , Japan , Polymerase Chain Reaction
12.
Jpn J Antibiot ; 54(8): 401-47, 2001 Aug.
Article in Japanese | MEDLINE | ID: mdl-11680053

ABSTRACT

The susceptibility of 3,058 bacterial strains isolated between January and March, 1997 from patients with severe infections in Japan to ciprofloxacin and other injectable antimicrobial agents was measured using broth microdilution method. Methicillin-resistant Staphylococcus aureus (MRSA) strains were generally sensitive to vancomycin, teicoplanin and arbekacin, and resistant to CPFX and other antibacterial agents. MIC90 of CPFX against Streptococcus pneumoniae, to which MIC of ampicillin was more than 4 micrograms/mL, was below 2 micrograms/mL. PRSP (Penicillin resistant S. pneumoniae), which was also resistant to cephalosporins and carbapenems, showed no cross-resistance to CPFX. The susceptibility of Gram-negative bacteria to CPFX was as high as that to carbapenems. Especially, MIC90 against Pseudomonas aeruginosa was 2 micrograms/mL. 3 strains of isolated 446 P. aeruginosa strains had blaIMP gene. CPFX and pazufloxacin demonstrated good susceptibility with 0.25 microgram/mL of MIC to 2 strains of these 3 strains. The susceptibility rate of the most common isolates from patients suffering from lower respiratory tract infections excluding MRSA to CPFX was more than 80% (indication: % strains < pneumonia break point).


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Bacteria/isolation & purification , Bacterial Infections/microbiology , Drug Resistance, Microbial , Humans , Japan , Severity of Illness Index
13.
Epidemiol Infect ; 126(2): 197-204, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11349969

ABSTRACT

Aminoglycoside modifying enzymes (AMEs) are major factors which confer aminoglycoside resistance on bacteria. Distribution of genes encoding seven AMEs was investigated by multiplex PCR for 279 recent clinical isolates of enterococci derived from a university hospital in Japan. The aac(6')-aph(2"), which is related to high level gentamicin resistance, was detected at higher frequency in Enterococcus faecalis (42.5%) than in Enterococcus faecium (4.3%). Almost half of E. faecalis and E. faecium isolates possessed ant(6)-Ia and aph(3')-IIIa. The profile of AME gene(s) detected most frequently in individual strains of E. faecalis was aac(6')aph(2") + ant(6)-Ia + aph(3')-IIIa, and isolates with this profile showed high level resistance to both gentamicin and streptomycin. In contrast, AME gene profiles of aac(6')-Ii+ ant(6)-Ia+aph(3')-IIIa, followed by aac(6')-Ii alone, were predominant in E. faecium. Only one AME gene profile of ant(6)-Ia+aph(3')-IIIa was found in Enterococcus avium. The ant(4')-Ia and ant(9)-Ia, which have been known to be distributed mostly among Staphylococcus aureus strains, were detected in a few enterococcal strains. An AME gene aph(2")-Ic was not detected in any isolates of the three enterococcal species. These findings indicated a variety of distribution profiles of AME genes among enterococci in our study site.


Subject(s)
Anti-Bacterial Agents/pharmacology , Enterococcus faecalis/genetics , Enterococcus faecium/genetics , Aminoglycosides , Enterococcus faecalis/drug effects , Enterococcus faecalis/enzymology , Enterococcus faecium/drug effects , Enterococcus faecium/enzymology , Humans , Microbial Sensitivity Tests , Polymerase Chain Reaction
14.
Plant Mol Biol ; 45(3): 353-63, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11292080

ABSTRACT

Glycinebetaine is an important osmoprotectant in bacteria, plants, and animals, but only little information is available on the synthesis of glycinebetaine in tree plants. Among four mangrove species, glycinebetaine could be detected only in Avicennia marina. Pinitol was the main osmoprotectant in the other three species. The level of glycinebetaine in A. marina increased under high salinity. Betaine-aldehyde dehydrogenase (BADH) was detected in all four species, but choline monooxygenase could not be detected. A cDNA library was constructed from the leaves of A. marina. Two kinds of BADH cDNAs were isolated, one homologous to the spinach chloroplast BADH, and the other with unique residues SKL at the end of C-terminus. The BADH transcription levels of the former were higher than those of the latter. The levels of the former BADH increased at high salinity whereas those of the latter were independent of salinity. BADHs were expressed in Escherichia coli and purified. Two kinds of A. marina BADHs exhibited similar kinetic and stability properties, but were significantly different from those of spinach BADH. A. marina BADHs efficiently catalyzed the oxidation of betainealdehyde, but not the oxidation of omega-aminoaldehydes and were more stable at high temperature than the spinach BADH.


Subject(s)
Aldehyde Oxidoreductases/genetics , Betaine/metabolism , Plants, Medicinal/genetics , Aldehyde Oxidoreductases/metabolism , Amino Acid Sequence , Betaine-Aldehyde Dehydrogenase , Calcium Chloride/pharmacology , Carbohydrate Metabolism , Cloning, Molecular , DNA, Complementary/chemistry , DNA, Complementary/genetics , Dose-Response Relationship, Drug , Enzyme Stability , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Plant/drug effects , Hot Temperature , Isoenzymes/genetics , Molecular Sequence Data , Osmolar Concentration , Oxidation-Reduction/drug effects , Oxygenases/metabolism , Plant Leaves/drug effects , Plant Leaves/enzymology , Plant Leaves/genetics , Plants, Medicinal/enzymology , Plants, Medicinal/metabolism , Potassium Chloride/pharmacology , Proline/metabolism , RNA, Messenger/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Sodium Chloride/pharmacology , Species Specificity , Spinacia oleracea/enzymology , Substrate Specificity , Tissue Distribution , gamma-Aminobutyric Acid/metabolism
15.
Anal Sci ; 17(1): 199-203, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11993663

ABSTRACT

Diazacrown ethers having two carbodithioate groups were synthesized, and their spectrophotometric properties were studied. Diammonium 1,4,10,13-tetraoxa-7,16-diazacycrooctadecane-N,N'-bis(carbodithioate) (DA18CC) and ammonium 1,4,10-trioxa-7,13-diazacycropentadecane-N,N'-bis(carbodithioate) (DA15CC) reacted with most heavy-metal ions through their two carbodithioate groups, and also reacted with alkali-metal ions or alkaline earth-metal ions through their diazacrown rings. Although the UV-VIS absorption spectra of DA18CC and DA15CC were hardly influenced by the addition of alkali-metal ions or alkaline earth-metal ions, the spectra of some heavy-metal chelates of DA18CC and DA15CC were influenced. The composition ratio (metal:ligand) of Cu(II) and Pb(II) chelates of DA18CC and DA15CC was altered from 1:1 to 1:2 by the addition of alkali-metal ions or alkaline earth-metal ions. It is suggested that the change in the absorption spectra and the composition ratio of the chelates can be attributed to an alteration of the equilibrium among species of the heavy-metal chelates of DA18CC and DA15CC due to the coordination of alkali-metal ions or alkaline earth-metal ions into the diazacrown ring.

16.
Cytotechnology ; 35(1): 35-42, 2001 Jan.
Article in English | MEDLINE | ID: mdl-19003279

ABSTRACT

We attempted to identify the genes involved in cellularsenescence, telomere maintenance and telomerase regulationthrough subtractive screening of cDNA libraries prepared froma human lung adenocarcinoma cell line A549 and its sublinesnamed A5DC7, CK and AST-9. Cell phenotypes of A5DC7, CK andAST-9 are normal cell-like, cancer cell-like and intermediate,respectively. These cell lines have different phenotypes interms of telomerase activity and telomere maintenance, andthus are thought to be useful for identifying the genesinvolved in cellular senescence and telomerase regulation. In this study, we identified 86 independent cDNA clones bysubtractive screening. Among these cDNA clones, subtractingA5DC7 cDNAs from A549 cDNAs and CK cDNAs gave 7 and 3 cDNAclones which highly and specifically expressed in tester celllines. Genes corresponding to these 10 cDNA clones mightparticipate in maintaining cancer-cell phenotypes. As aresult of database searching, each four of A549 specific cDNAclones are found to correspond to known cDNAs. Each two ofA549 specific and two of CK specific cDNA clones have highhomology to independent ESTs. Sequences having homology toeach one of A549 specific and one of CK specific cDNA cloneshave not been deposited in the Genbank database, indicatingthat these two cDNA clones are part of novel genes. Weanticipate that their involvement in telomerase regulationand/or senescence program can be clarified by functionalanalysis using each full-length cDNA.

17.
Cytotechnology ; 36(1-3): 137-44, 2001 Jul.
Article in English | MEDLINE | ID: mdl-19003324

ABSTRACT

Serum-free mouse embryo (SFME) cells were established by D. Barnes et al., and are known to be a neural stem cell line, which differentiate into astrocytes upon treatment with TGF-beta. Therefore, SFME cells is thought to be a model well suited to analyze the differentiation mechanism of neural stem cells. Until now, we have investigated the regulation mechanisms of telomerase activity and telomere length in human cancer and normal cells. Telomerase is the enzyme responsible for the synthesis and maintenance of telomere repeats located at chromosomal ends and is normally expressed in embryonic and germline cells, but not in most normal cells. Here, using SFME cells, we attempted to analyze the regulation mechanism of telomerase activity in neural stem cells and to detect a change upon differentiation into astrocytes. When SFME cells were cultured in the presence of TGF-beta, cells showed anelongated morphology and decreased its growth to 50% of control culture. Cells also expressed the glial fibrillary acidic protein (GFAP), a marker for astrocytes,indicating that TGF-beta induced differentiation in SFME cells from neural stem cells into astrocytes. At the same time,TGF-beta also inhibited telomerase activity and repressed the expression of the mouse telomerase reverse transcriptase(mTERT), demonstrating that SFME cells was vested with a finite replicative life span upon treatment with TGF-beta. To understand the mechanisms regulating mTERT levels during differentiation into astrocytes, we have estimated the expression level of c-myc, which is known to be a key molecule in activating the TERT promoter. As a result, TGF-beta-treated SFME cells were shown to repress the expression of c-myc. Furthermore, promoter analysis, using the 5'-region of the mTERT gene, which possess two E-box elements bound to c-Myc/Max, demonstrated that mTERT promoter activity greatly decreased in TGF-beta-treated SFME cells as compared to non-treated SFME cells. These suggest that c-myc might play a critical role in the expression of mTERT, and that down-regulation of c-myc dependent upon the astrocytic differentiation in SFME cells might cause the repression of mTERT in TGF-beta-treated SFME cells.

18.
Anal Sci ; 17(12): 1421-4, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11783792

ABSTRACT

The determination of trace amounts of boron in steel by reversed-phase high-performance liquid chromatography (HPLC) is described. As a derivatizing reagent for the HPLC determination of boron, 8-hydroxy-1-(salicylideneamino)-3,6-naphtalenedisulfonic acid (azomethine-H) was used with a spectrophotometric detection. A peak of boron-azomethine-H chelate was resolved from other peaks using an acetonitrile-water (29 + 71 m/m) eluent containing 8 x 10(-3) mol kg(-1) tetrabutylammonium bromide and 5 x 10(-3) mol kg(-1) acetate buffer (pH 5.0). The lower determination limit (10sigma) of boron was 3.3 x 10(-8) mol dm(-3) for a solution injected into HPLC, which is translated to 0.09 microgB/g when 0.1 g of a steel sample was subjected to the analysis. The analytical results of certified steel samples were in good agreement with the guaranteed values. The addition of ethylenediamine-N,N,N',N'-tetraacetate as a masking agent for the iron(III) matrix with the optimized eluent enables one to achieve the direct determination of trace amounts of boron in such steel sample solutions without any tedious matrix removal or preconcentration.

19.
Jpn J Antibiot ; 53(6): 387-408, 2000 Jun.
Article in Japanese | MEDLINE | ID: mdl-10955236

ABSTRACT

The surveillance study was conducted to determine the antimicrobial activity of fluoroquinolones (ofloxacin, levofloxacin, ciprofloxacin, tosufloxacin) and other 20 antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. The resistance to fluoroquinolones was remarkable in Enterococci, methicillin-resistant staphylococci and Pseudomonas aeruginosa from UTI. However, many of the common pathogens such as Streptococcus pneumoniae including penicillin-resistant isolates, methicillin-susceptible Stahylococcus aureus, Moraxella catarrhalis, the family of Enterobacteriaceae, Haemophilus influenzae including ampicillin-resistant isolates have been kept to be susceptible to fluoroquinolones. About 90% of P. aeruginosa isolates from RTI were susceptible to fluoroquinolones. In conclusion, the results from this surveillance study suggest that fluoroquinolones are useful in the treatment of various bacterial infections including respiratory infections.


Subject(s)
Anti-Infective Agents/pharmacology , Fluoroquinolones , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Ciprofloxacin/pharmacology , Drug Resistance, Microbial , Humans , Levofloxacin , Naphthyridines/pharmacology , Ofloxacin/pharmacology , Respiratory Tract Infections/microbiology , Urinary Tract Infections/microbiology
20.
Jpn J Antibiot ; 53(3): 157-70, 2000 Mar.
Article in Japanese | MEDLINE | ID: mdl-10834147

ABSTRACT

During October and December of each year of from 1994 to 1996, 3,849 strains of 10 species of bacteria were isolated from clinical materials in 21 institutions nationwide. The minimum inhibitory concentrations (MICs) for these bacteria of four carbapenems (imipenem [IPM], panipenem [PAPM], meropenem [MEPM], and biapenem [BIPM]) and other representative antibacterial agents were measured to investigate annual changes in antibacterial activity. Carbapenems showed potent activity against methicillin-sensitive S. aureus (MSSA), S. pneumoniae, E. faecalis, H. influenzae, E. coli, K. pneumoniae, E. cloacae, S. marcescens, and the B. fragilis group, with the activity being stable. However, these drugs showed weak activity against methicillin-resistant S. aureus (MRSA) and P. aeruginosa. The antibacterial activity (MIC90) against the tested organisms generally remained stable. Particularly, there was annual improvement of the MIC90 values of IPM and BIPM for S. pneumoniae, as well as the values of IPM and PAPM for H. influenzae, and those of IPM, PAPM, and BIPM for S. marcescens. On the other hand, the activity of carbapenems (including IPM) against MRSA was not necessarily strong, but there was annual improvement of MIC90 values.


Subject(s)
Bacteria/drug effects , Carbapenems/pharmacology , Bacteria/isolation & purification , Drug Resistance, Microbial , Humans , Imipenem/pharmacology , Japan , Meropenem , Multicenter Studies as Topic , Thienamycins/pharmacology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...